Form D Friday: Qatar Investment Authority backs Boston biotech company

Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses.

Form D Friday: Qatar Investment Authority backs Boston biotech company

Form D Friday is a Boston Business Journal feature highlighting regulatory filings from Boston-area companies raising capital for new projects or expanding their businesses. Form D reports are a type of SEC form used to file a notice of exempt offerings of securities. The SEC requires companies file the notice within 15 days after the first sale of securities in the offering. These forms don't include a lot of details but can provide clues as to what investors and business owners are planning. If you have any tips or comments about new Boston-area fundraises, email Lucy at EMAIL

This week, investors backed two biotech firms and a marketing tech company, based on the filings we tracked between Jan. 9 and Jan. 13. Overall, the companies we tracked raised over $86 million.

Here are some of the companies that raised money this week:

Redpoint Global Inc.: $60,000

Wellesley-based Redpoint Global Inc. raised $60,000 in options from a single investor, according to a Form D dated Jan. 12. Founded in 2006, the company provides a customer data platform to help marketers optimize their campaigns. It has additional offices in London and the Philippines.

Alzheon Inc.: $1.7 million

Six investors contributed $1.7 million to the latest equity offering of Framingham biotechnology company Alzheon Inc., according to a Form D dated Jan. 11. Total amount of the offering is $50 million. The company's Alzheimer's clinical candidate, ALZ-801, is in Phase 3 development. Last week, the U.S. Food and Drug Administration granted accelerated approval to a second Alzheimer's disease drug made by Biogen Inc. with its Japanese partner Eisai Inc.

Ensoma Inc.: $85 million

Genomic medicines company Ensoma Inc. announced last week the completion of an $85 million Series B financing round co-led by Arix Bioscience and 5AM Ventures. Other investors include the Bill & Melinda Gates Foundation and Qatar Investment Authority, or QIA, which in Greater Boston is one of the backers of cybersecurity unicorn Snyk Ltd. In a Form D dated Jan. 6, Boston-based Ensoma said that $79 million in equity financing came from 79 investors.